Common Contracts
27 similar Incentive Stock Option Agreement contracts by OvaScience, Inc., Civitas Therapeutics, Inc., Collegium Pharmaceutical Inc, others
SIGILON THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 EQUITY INCENTIVE PLANIncentive Stock Option Agreement • November 13th, 2020 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations
Desktop Metal, Inc. Incentive Stock Option Agreement Granted Under 2015 Stock Incentive PlanIncentive Stock Option Agreement • October 15th, 2020 • Trine Acquisition Corp. • Computer peripheral equipment, nec
FOGHORN THERAPEUTICS INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLANIncentive Stock Option Agreement • August 28th, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations
SIGILON THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 EQUITY INCENTIVE PLANIncentive Stock Option Agreement • August 21st, 2020 • Sigilon Therapeutics, Inc. • Pharmaceutical preparations
KEROS THERAPEUTICS, INC. Incentive Stock Option Agreement Granted Under 2017 Stock Incentive PlanIncentive Stock Option Agreement • March 16th, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations
KEROS THERAPEUTICS, INC. Incentive Stock Option Agreement Granted Under 2017 Stock Incentive PlanIncentive Stock Option Agreement • January 21st, 2020 • Keros Therapeutics, Inc. • Pharmaceutical preparations
FULCRUM THERAPEUTICS INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLANIncentive Stock Option Agreement • June 21st, 2019 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations
FULCRUM THERAPEUTICS INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2016 STOCK INCENTIVE PLANIncentive Stock Option Agreement • May 1st, 2019 • Fulcrum Therapeutics, Inc. • Pharmaceutical preparations
CASA SYSTEMS, INC. Incentive Stock Option Agreement Granted Under 2011 Stock Incentive PlanIncentive Stock Option Agreement • November 17th, 2017 • Casa Systems Inc • Radio & tv broadcasting & communications equipment
SYROS PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2012 Equity Incentive PlanIncentive Stock Option Agreement • June 3rd, 2016 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
SPRING BANK PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive PlanIncentive Stock Option Agreement • January 5th, 2016 • Spring Bank Pharmaceuticals, Inc. • Pharmaceutical preparations
EDITAS MEDICINE, INC. Incentive Stock Option Agreement Granted Under 2013 Stock Incentive PlanIncentive Stock Option Agreement • January 4th, 2016 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
SYROS PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2012 Equity Incentive PlanIncentive Stock Option Agreement • November 20th, 2015 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
EDITAS MEDICINE, INC. Incentive Stock Option Agreement Granted Under 2013 Stock Incentive PlanIncentive Stock Option Agreement • October 16th, 2015 • Editas Medicine, Inc. • Biological products, (no disgnostic substances)
COLLEGIUM PHARMACEUTICAL, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • April 2nd, 2015 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations
Collegium Pharmaceutical, Inc. (the “Company”) hereby grants the following stock option pursuant to its 2014 Stock Incentive Plan (the “Plan”). The terms and conditions attached hereto are also a part hereof.
COLLEGIUM PHARMACEUTICAL, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Reincorporation Replacement Option for Options Originally Granted under 2002 Stock Option Plan)Incentive Stock Option Agreement • March 3rd, 2015 • Collegium Pharmaceutical Inc • Pharmaceutical preparations
COLLEGIUM PHARMACEUTICAL, INC. Incentive Stock Option Agreement Granted Under 2014 Stock Incentive Plan (Reincorporation Replacement Option for Options Originally Granted under 2012 Stock Incentive Plan)Incentive Stock Option Agreement • March 3rd, 2015 • Collegium Pharmaceutical Inc • Pharmaceutical preparations
SPARK THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2014 STOCK INCENTIVE PLANIncentive Stock Option Agreement • September 24th, 2014 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)
Civitas Therapeutics, Inc. Incentive Stock Option Agreement Granted Under 2010 Stock Incentive PlanIncentive Stock Option Agreement • September 15th, 2014 • Civitas Therapeutics, Inc. • Biological products, (no disgnostic substances)
KOLLTAN PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2008 Equity Incentive PlanIncentive Stock Option Agreement • September 12th, 2014 • Kolltan Pharmaceuticals Inc • Pharmaceutical preparations
KOLLTAN PHARMACEUTICALS, INC. Incentive Stock Option Agreement Granted Under 2008 Equity Incentive PlanIncentive Stock Option Agreement • August 8th, 2014 • Kolltan Pharmaceuticals Inc • Pharmaceutical preparations
Civitas Therapeutics, Inc. Incentive Stock Option Agreement Granted Under 2010 Stock Incentive PlanIncentive Stock Option Agreement • May 12th, 2014 • Civitas Therapeutics, Inc. • Biological products, (no disgnostic substances)
Epizyme, Inc. Incentive Stock Option Agreement Granted Under 2008 Stock Incentive PlanIncentive Stock Option Agreement • April 18th, 2013 • Epizyme, Inc. • Pharmaceutical preparations
OVASCIENCE, INC. Incentive Stock Option Agreement Granted Under 2012 Stock Incentive PlanIncentive Stock Option Agreement • May 17th, 2012 • OvaScience, Inc. • In vitro & in vivo diagnostic substances
OVASCIENCE, INC. Incentive Stock Option Agreement Granted Under 2011 Stock Incentive PlanIncentive Stock Option Agreement • May 17th, 2012 • OvaScience, Inc. • In vitro & in vivo diagnostic substances
OVASCIENCE, INC. Incentive Stock Option Agreement Granted Under 2011 Stock Incentive PlanIncentive Stock Option Agreement • April 11th, 2012 • OvaScience, Inc.
OVASCIENCE, INC. Incentive Stock Option Agreement Granted Under 2012 Stock Incentive PlanIncentive Stock Option Agreement • April 11th, 2012 • OvaScience, Inc.
